Tissular toxicity of hyperglycæmia: Perspectives for treatment;Toxicité tissulaire du glucose et ses perspectives thèrapeutiques

Revue du Praticien

Volumn 51, Issue 16, 2001, Pages 1765-1768

  Larger, E ^a   Maree, M ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALDOSE REDUCTASE INHIBITOR; AMINOGUANIDINE; ANTIOXIDANT; FREE RADICAL; GLUCOSE; HEXOSAMINE; POLYOL; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

BIOCHEMISTRY; CAPILLARY FLOW; CHRONIC DISEASE; DIABETIC ANGIOPATHY; ENDOTHELIUM CELL; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; TISSUE INJURY; TREATMENT PLANNING; VASCULAR ENDOTHELIUM;

ANTIOXIDANTS; BLOOD GLUCOSE; CLINICAL TRIALS, PHASE II; CLINICAL TRIALS, PHASE III; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC RETINOPATHY; ENDOTHELIUM, VASCULAR; FREE RADICALS; FRUCTOSE-BISPHOSPHATE ALDOLASE; GLUCOSE; HEMODYNAMIC PROCESSES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; OXIDOREDUCTASES; PROSPECTIVE STUDIES; PROTEIN KINASE C; TIME FACTORS;

EID: 19244373413     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Hyperglycemic pseudohypoxia and diabetic complications
2. Search for a biochemical basis of diabetic microangiopathy
3. Hemodynamic factors in the genesis of diabetic microangiopathy
4. Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells
5. Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus
6. The retinal blood flow in diabetes
7. Microvascular function in human diabetes. A physiological perspective
8. The nature of the glomerulus pressure induced and metabolic aberrations - (Chapter I)
9. Unilateral nodular diabetic glomerulosclerosis (Kimmelstiel-Wilson)
10. Unilateral complications in diabetic retinopathy
11. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
12. Bases biochimiques du vieillissement: Le glucose joue-t-il un rôle ?
13. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-I expression by increasing Sp1 glycosylation
14. High glucose-induced transforming growth factor beta I production is mediated by the hexosamine pathway in porcine glomerular mesangial cells
15. Theoretical mechanisms by which hyperglycemia and insulin resistance could cause cardiovascular diseases in diabetes
16. Lilly lecture 1993. Glycation and diabetic complications
17. Aldose reductase in glucose toxicity: A potential target for the prevention of diabetic complications
18. Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens
19. BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells
20. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
21. Progression of incipient diabetic retinopathy during good glycemic control
22. Retinopathy and nephropathy in patients with type I diabetes four years after a trial of intensive therapy
23. Reversal of lesions of diabetic nephropathy after pancreas transplantation
24. The missing link: A single unifying mechanism for diabetic complications
25. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
26. Intensive blood glucose control with sulfonyureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
27. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor
28. An agent cleaving glucose-derived protein crosslinks in vitro and in vivo
29. A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys
30. Effect of angiotensin-converting-enzyme (ACE) inhibitor Trandolapril on human diabetic neuropathy, randomised double-blind controlled trial